Amitriptyline administered after consolidation of inhibitory avoidance does not affect memory retrieval

Psicothema

Volumn 18, Issue 3, 2006, Pages 514-518

  Parra, Andrés ^a   Everss, Estrella ^a   Arenas, M Carmen ^a   Vinader Caerols, Concepción ^a   Monleón, Santiago ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; AMITRIPTYLINE;

ANIMAL; ARTICLE; DRUG EFFECT; ESCAPE BEHAVIOR; EVALUATION; FEMALE; INHIBITION (PSYCHOLOGY); MALE; MEMORY; MOUSE; RANDOMIZATION; RECALL;

ADRENERGIC UPTAKE INHIBITORS; AMITRIPTYLINE; ANIMALS; ESCAPE REACTION; FEMALE; INHIBITION (PSYCHOLOGY); MALE; MEMORY; MENTAL RECALL; MICE; RANDOM ALLOCATION;

EID: 33750600292     PISSN: 02149915     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Abe, M., Tabata, R., Saito, K., Matsuda, T., Baba, A. and Egawa, M. (1996). Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models. The Journal of Pharmacology and Experimental Therapeutics, 278, 898-905.
2. Arenas, M.C., Vinader-Caerols, C., Monleón, S., Martos, A.J., Everss, E., Ferrer-Añó, A. and Parra, A. (2006). Are the effects of the antidepressants amitriptyline, maprotiline and fluoxetine on inhibitory avoidance state-dependent? Behavioural Brain Research, 166, 150-158.
3. Baldessarini, R.J. (2001). Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In J.G. Hardman, L.E. Limbird and A.G. Oilman (comps.): Goodman & Gilman's The pharmacological basis of therapeutics (pp. 447-483). Nueva York: McGraw-Hill.
4. Barbui, C. and Hotopf, M. (2001). Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. British Journal of Psychiatry, 178, 129-144.
5. Blandina, P., Efoudebe, M., Cenni, G., Mannaioni, P. and Passani, M.B. (2004). Acetylcholine, histamine and cognition: two sides of the same coin. Learning and Memory, 11, 1-8.
6. Bureš, J., Burešová, O. and Huston, J.P. (1983). Techniques and basic experiments for the study of brain and behaviour. Amsterdam: Elsevier.
7. Cimadevilla, J.M., Conejo, N.M., Miranda, R. and Arias, J.L. (2004). Sex differences in the Morris water maze in young rats: temporal dimensions. Psicothema, 16, 611-614.
8. de Pablo, J.M., Parra, A., Segovia, S. and Guillamón, A. (1989). Learned immobility explains the behaviour of rats in the forced swimming test. Physiology and Behavior, 46, 229-237.
9. Ennaceur, A. and Delacour, J. (1988). A new one-trial test for neurobiological studies of memory in rats. I: Behavioral data. Behavioural Brain Research, 31, 47-59.
10. Everss, E., Arenas, M.C., Vinader-Caerols, C., Monleón, S. and Parra, A. (2005). Piracetam counteracts the effects of amitriptyline on inhibitory avoidance in CD1 mice. Behavioural Brain Research, 159, 235-242.
11. File, S.E. (2001). Factors controlling measures of anxiety and responses to novelty in the mouse. Behavioural Brain Research, 125, 151-157.
12. Food and Drug Administration. Guidance for industry and reviewers. Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Available at: http://www.fda.gov/cber/gdlns/dose.htm. Accessed September 06, 2005.
13. Frackiewicz, E.J., Sramek, J.J. and Cutler, N.R. (2000). Gender differences in depression and antidepressant pharmacokinetics and adverse events. The Annals of Pharmacotherapy, 34, 80-88.
14. Gold, P.E. (1986). The use of avoidance training in studies of modulation of memory storage. Behavioral and Neural Biology, 46, 87-98.
15. Gold, P.E. (2003). Acetylcholine modulation of neural systems involved in learning and memory. Neurobiology of Learning and Memory, 80, 194-210.
16. Gumnick, J.F. and Nemeroff, C.B. (2000). Problems with currently available antidepressants. Journal of Clinical Psychiatry, 61(Suppl 10), 5-15.
17. Izquierdo, I. and Medina, J.H. (1997). Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiology of Learning and Memory, 68, 285-316.
18. Izquierdo, I., Medina, J.H., Izquierdo, L.A., Barros, D.M., de Souza, M.M. and Mello e Souza, T. (1998). Short- and long-term memory are differentially regulated by monoaminergic systems in the rat brain. Neurobiology of Learning and Memory, 69, 219-224.
19. Lin, J.H. (1995). Species similarities and differences in pharmacokinetics. Drug Metabolism and Disposition, 23, 1.008-1.021.
20. Lister, R.G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92, 180-185.
21. Martos, A.J., Vinader-Caerols, C., Monleón, S., Arenas, M.C. and Parra, A. (1999). Efectos de la fisostigmina y de la nicotina sobre la inmovilidad aprendida en la prueba de natación forzada. Psicothema, 11, 631-639.
22. Monleón, S., Urquiza, A., Arenas, M.C., Vinader-Caerols, C. and Parra, A. (2002). Chronic administration of fluoxetine impairs inhibitory avoidance in male but not female mice. Behavioural Brain Research, 136, 483-488.
23. Palucha, A. and Pilc, A. (2002). On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants. Polish Journal of Pharmacology, 54, 581-586.
24. Parra, A., Everss, E., Monleón, S., Vinader-Caerols, C. and Arenas, M.C. (2002). Effects of acute amitriptyline administration on memory, anxiety and activity in male and female mice. Neuroscience Research Communications, 31, 135-144.
25. Parra, A., Vinader-Caerols, C., Monleón, S. and Simón, V.M. (1999). Learned immobility is also involved in the forced swimming test in mice. Psicothema, 11, 239-246.
26. Platel, A. and Porsolt, R.D. (1982). Habituation of exploratory activity in mice: a screening test for memory enhancing drugs. Psychopharmacology, 78, 346-352.
27. Porsolt, R.D., Le Pichon, M. and Jalfre, M. (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature, 266, 730-732.
28. Richelson, E. (2003). Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. Journal of Clinical Psychiatry, 64(Suppl 13), 5-12.
29. Rodgers, R.J. and Dalvi, A. (1997). Anxiety, defence and the elevated plus-maze. Neuroscience and Biobehavioral Reviews, 21, 801-810.
30. Rodgers, R.J. and Johnson, N.J. (1995). Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacology Biochemistry and Behavior, 52, 297-303.
31. Shapiro, B.H., Agrawal, A.K. and Pampori, N.A. (1995). Gender differences in drug metabolism regulated by growth hormone. The International Journal of Biochemistry and Cell Biology, 27, 9-20.
32. Shelton, R.C. (2000). Cellular mechanisms in the vulnerability to depression and response to antidepressants. The Psychiatric Clinics of North America, 23, 713-729.
33. Shilling, P.D. and Kelsoe, J.R. (2002). Functional genomics approaches to understanding brain disorders. Pharmacogenomics, 3, 31-45.
34. StatSoft, Inc. (2000). Statistica for Windows (Computer program manual). Tulsa, OK: StatSoft Inc.
35. Vinader-Caerols, C., Ferrer-Añó, A., Arenas, M.C., Monleón, S. and Parra, A. (2002). La maprotilina anula las diferencias entre ratones machos y hembras en el laberinto de agua de Morris. Psicothema, 14, 823-827.